LIVN - リバノバ (LivaNova PLC) リバノバ

 LIVNのチャート


 LIVNの企業情報

symbol LIVN
会社名 LivaNova PLC (リバノバ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 リバノワ(LivaNova PLC)は治療ソリューションの開発に集中する医療機器会社である。同社には、2つの事業セグメントがある。心臓手術事業は心血管手術製品の開発、製造及び販売に従事する。心臓手術製品には、人工肺、心肺装置、自家輸血、機械式心臓弁及び心臓弁がある。神経調節事業は、薬剤耐性てんかん及び治療抵抗性うつ病の治療のための神経調節治療の設計、開発及び販売に従事する。   リバノバイギリスの医療品企業。主に心臓欠陥疾患の病理を扱う製品と医療サ―ビスに従事する。心臓外科手術と不整脈や心拍管理、心肺バイパス手術のための製品やサ―ビスを提供する他、癲癇や鬱病治療のための神経調整に基づく医療機器を提供する。また、心臓麻痺と僧帽弁閉鎖不全の分野においても、新しい治療法の開発に取り組む。本社所在地はロンドン。   
本社所在地 20 Eastbourne Terrace London W2 6LG GBR
代表者氏名 Daniel Jeffrey Moore ダニエルジェフリームーア
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +44 20-3325-0662
設立年月日 42036
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 4500人
url www.livanova.com
nasdaq_url https://www.nasdaq.com/symbol/livn
adr_tso
EBITDA EBITDA(百万ドル) 182.51100
終値(lastsale) 118.18
時価総額(marketcap) 5742595114.66
時価総額 時価総額(百万ドル) 5519.558
売上高 売上高(百万ドル) 943.68100
企業価値(EV) 企業価値(EV)(百万ドル) 5633.179
当期純利益 当期純利益(百万ドル) 60.54600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 LivaNova PLC revenues increased 11% to $537.9M. Net income before extraordinary items decreased 37% to $37.4M. Revenues reflect Cardiopulmonary segment increase from $107.3M to $261.8M Neuromodulation segment increase of 34% to $204.5M United States segment increase of 10% to $266.1M. Net income was offset by Sell./Gen./Admin. increase of 25% to $227.6M (expense).

 LIVNのテクニカル分析


 LIVNのニュース

   Epilepsy Market Undertake Strapping Growth By 2027 With LivaNova PLC, GlaxoSmithKline PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, GW Pharmaceuticals PLC, Novartis AG, Johnson & Johnson Services Inc., Abbott Laboratories, Becton Dickinson and Company  2021/03/22 09:06:26 OpenPR
Epilepsy research report provides deep insights into the Global Epilepsy market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the Epilepsy during
   Cardiopulmonary Autotransfusion Systems Market is Thriving Worldwide 2021-2025 | Leading Players - Medtronic, Terumo, Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Stryker  2021/03/17 11:05:59 OpenPR
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Cardiopulmonary Autotransfusion Systems Market” Research Report 2021 provides an in-depth analysis of the Cardiopulmonary Autotransfusion Systems with the forecast of market size and
   Active Implantable Medical Devices Market 2021 - 2027 Size, Industry Share, Growth, COVID-19 Analysis, Top Key Players : Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive  2021/03/16 12:07:43 OpenPR
Rise in prevalence of chronic diseases, supportive initiatives from medical health insurance companies for critical issues, and increase in awareness regarding different types of implants drive the growth of the global medical implant market. However, high cost of treatment and
   Autotransfusion Device Market With Leading Players like Medtronic, Fresenius SE & Co. KGaA, Teleflex Incorporated BD, Zimmer Biomet, BraileBiomedica, Haemonetics Corporation, SARSTEDT AG and Co. KG, LivaNova PLC, Redax S.p.A.  2021/03/15 08:28:43 OpenPR
An off-the-shelf report on Autotransfusion Device Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as
   Innovative Report on Artificial Heart Lung Machines Market with Competitive Analysis and Top Key Companies (Medtronic, LivaNova, Getinge, Terumo CVS, Braile Biomedica) | Forecasts 2021-2025  2021/03/04 12:31:24 OpenPR
Global Artificial Heart Lung Machines Market Synopsis: The report covers a forecast and an analysis of the Artificial Heart Lung Machines Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with
   Innovative Report on Artificial Heart Lung Machines Market with Competitive Analysis and Top Key Companies (Medtronic, LivaNova, Getinge, Terumo CVS, Braile Biomedica) | Forecasts 2021-2025  2021/03/04 12:31:24 OpenPR
Global Artificial Heart Lung Machines Market Synopsis: The report covers a forecast and an analysis of the Artificial Heart Lung Machines Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with
   Permira bids for $3.7bn medical device maker LivaNova  2021/03/03 20:53:43 Financial Times
Buyout group made offer last month and talks are ongoing, people familiar with matter say
   LivaNova Reports Fourth Quarter and Full-Year 2020 Results  2021/02/24 11:00:00 Business Wire
LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC today reported results for the quarter and full-year ended December 31, 2020.
   Earnings Scheduled For February 24, 2021  2021/02/24 08:35:09 Benzinga
Companies Reporting Before The Bell • Pinnacle West Capital (NYSE: PNW ) is expected to report quarterly earnings at $0.04 per share on revenue of $715.74 million. • Itron (NASDAQ: ITRI ) is projected to report quarterly earnings at $0.30 per share on revenue of $569.75 million. • BGC Partners (NASDAQ: BGCP ) is expected to report quarterly earnings at $0.12 per share on revenue of $470.95 million. • Bausch Health Cos (NYSE: BHC ) is projected to report quarterly earnings at $1.12 per share on revenue of $2.17 billion. • Cheniere Energy Partners, LP Cheniere Energy Partners, LP Common Units (AMEX: CQP ) is expected to report quarterly earnings at $0.69 per share on revenue of $1.73 billion. • Casper Sleep (NYSE: CSPR ) is expected to report quarterly loss at $0.35 per share on revenue of $138.15 million. • Caesarstone (NASDAQ: CSTE ) is projected to report earnings for its fourth quarter. • China Yuchai Intl (NYSE: CYD ) is projected to report earnings for its fourth quarter. • Elanco Animal Health (NYSE: ELAN ) is estimated to report quarterly earnings at $0.
   Prosthetic Heart Valve Market Statistics, Facts and Figures, Investment Trends, Key Players and Forecast by 2028 |Key Players: Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., LivaNova PLC  2021/02/01 22:52:31 OpenPR
Global Prosthetic Heart Valve Market to Grow Rapidly due to Increasing Application in Healthcare Sector Over the projected period, the growing prevalence of valve heart disease (VHD) is expected to fuel the growth of the global demand for prothetic heart valves.
   Prosthetic Heart Valve Market Statistics, Facts and Figures, Investment Trends, Key Players and Forecast by 2028 |Key Players: Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., LivaNova PLC  2021/02/01 22:52:31 OpenPR
Global Prosthetic Heart Valve Market to Grow Rapidly due to Increasing Application in Healthcare Sector Over the projected period, the growing prevalence of valve heart disease (VHD) is expected to fuel the growth of the global demand for prothetic heart valves.
   Medical Implant Market Outlook 2021 - 2027 | Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive Inc.  2021/01/29 08:01:51 OpenPR
According to the report, the medical implants industry garnered $85.38 billion in 2019, and is projected to generate $147.46 billion by 2027, witnessing a CAGR of 7.2% from 2020 to 2027. Increase in prevalence of chronic diseases, supportive initiatives from medical
   Medical Implant Market 2021: Size, Share, Demand, Covid-19 Impact Analysis, Top Key Players Like Johnson and Johnson, Boston Scientific Corporation, Biotronik, LivaNova PLC  2021/01/25 06:41:16 OpenPR
According to the report published by Allied Market Research, The medical implants market accounted for $85.38 billion in 2019, and is expected to reach $147.46 billion by 2027, registering a CAGR of 7.2% from 2020 to 2027. Increase in prevalence of
   Congestive Heart Failure Treatment Devices Market Report- Opportunity, Analysis, Growth, Trends & Forecast TO 2027 | Abiomed, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Jarvik Heart, LivaNova PLC, Med  2021/01/13 13:07:52 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2021”. The Global Congestive Heart Failure Treatment Devices Market Report 2021 is a professional and in-depth study on
   Noctrix Health, Inc. Completes $17M Million Series B Financing  2021/01/11 14:00:00 PR Newswire
SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ -- Noctrix Health, Inc., a private medical device company, today announced it has completed a Series B financing of $17 million. The financing was co-led by Treo Ventures and OrbiMed, with participation from LivaNova PLC (NASDAQ: LIVN) and other…

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 リバノバ LIVN LivaNova PLC)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)